← Browse by Condition
Medical Condition

recurrent high grade glioma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07480941 Phase 1
Recruiting

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
View Trial →